A critical breakthrough in cancer study is occurring with the use of nanobodies to re-engage damaged p53. This essential malignant protector protein is frequently lost in several kinds of malignancies, resulting https://bookmarksoflife.com/story7707232/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-pathway-for-malignant-treatment